[1] Luccio-Camelo DC, Prins GS. Disruption of androgen receptor signaling in males by environmental chemicals. J Steroid Biochem, 2011; 127, 74−82. doi:  10.1016/j.jsbmb.2011.04.004
[2] Sun JF, Liu P, Li CY, et al. Probabilistic acute dietary exposure assessment of the Chinese population to cypermethrin residues. Food Addit Contam A, 2011; 28, 869−76. doi:  10.1080/19440049.2011.572928
[3] Alaa-Eldin EA, El-Shafei DA, Abouhashem NS. Individual and combined effect of chlorpyrifos and cypermethrin on reproductive system of adult male albino rats. Environ Sci Pollut R, 2017; 24, 1532−43. doi:  10.1007/s11356-016-7912-6
[4] Hu JX, Li YF, Li J, et al. Toxic effects of cypermethrin on the male reproductive system: with emphasis on the androgen receptor. J Appl Toxicol, 2013; 33, 576−85. doi:  10.1002/jat.1769
[5] Li YF, Pan C, Hu JX, et al. Effects of cypermethrin on male reproductive system in adult rats. Biomed Environ Sci, 2013; 26, 201−8.
[6] Schaufele F, Carbonell X, Guerbadot M, et al. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. P Natl Acad Sci USA, 2005; 102, 9802−7. doi:  10.1073/pnas.0408819102
[7] Hines M, Constantinescu M, Spencer D. Early androgen exposure and human gender development. Biol Sex Differ, 2015; 6, 3. doi:  10.1186/s13293-015-0022-1
[8] Xu LC, Liu L, Ren XM, et al. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro. Toxicol, 2008; 243, 59−65. doi:  10.1016/j.tox.2007.09.028
[9] Xu LC, Sun H, Chen JF, et al. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay. Toxicol Lett, 2006; 160, 151−7. doi:  10.1016/j.toxlet.2005.06.016
[10] Elbetieha A, Da'as SI, Khamas W, et al. Evaluation of the toxic potentials of cypermethrin pesticide on some reproductive and fertility parameters in the male rats. Arch Environ Con Tox, 2001; 41, 522−8. doi:  10.1007/s002440010280
[11] Dawar FU, Zuberi A, Azizullah A, et al. Effects of cypermethrin on survival, morphological and biochemical aspects of rohu (Labeo rohita) during early development. Chemosphere, 2016; 144, 697−705. doi:  10.1016/j.chemosphere.2015.09.007
[12] Lin HK, Altuwaijri S, Lin WJ, et al. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J BioL Chem, 2002; 277, 36570−6. doi:  10.1074/jbc.M204751200
[13] Daniels G, Jha R, Shen Y, et al. Androgen receptor coactivators that inhibit prostate cancer growth. Am J Clin Exp Urol, 2014; 2, 62−70.
[14] Gunther JR, Parent AA, Katzenellenbogen JA. Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors. Acs Chem Biol, 2009; 4, 435−40. doi:  10.1021/cb900043e
[15] Pan C, Liu YP, Li YF, et al. Effects of cypermethrin on the ligand-independent interaction between androgen receptor and steroid receptor coactivator-1. Toxicol, 2012; 299, 160−4. doi:  10.1016/j.tox.2012.05.022
[16] Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. P Natl Acad Sci Usa, 1996; 93, 5517−21. doi:  10.1073/pnas.93.11.5517
[17] Kollara A, Brown TJ. Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity. Cell Mol Life Sci, 2012; 69, 3895−909. doi:  10.1007/s00018-012-1000-y
[18] Dubbink HJ, Hersmus R, Pike AC, et al. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Mol Endocrinol, 2006; 20, 1742−55. doi:  10.1210/me.2005-0348
[19] Bellelli R, Castellone MD, Guida T, et al. NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. Mol Cell, 2014; 55, 123−37. doi:  10.1016/j.molcel.2014.04.031
[20] Hu YC, Yeh S, Yeh SD, et al. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. J Biol Chem, 2004; 279, 33438−46. doi:  10.1074/jbc.M401781200
[21] Kollara A, Brown TJ. Variable expression of nuclear receptor coactivator 4 (NcoA4) during mouse embryonic development. J Histochem Cytochem, 2010; 58, 595−609. doi:  10.1369/jhc.2010.955294
[22] Bengtsen M, Sorensen L, Aabel L, et al. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin. Bba, 2017; 1860, 751−60.
[23] Heitzer MD, DeFranco DB. Hic-5/ARA55: a prostate stroma-specific AR coactivator. Steroids, 2007; 72, 218−20. doi:  10.1016/j.steroids.2006.11.010
[24] Fujimoto N, Yeh S, Kang HY, et al. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Korean Soc Appl Bi, 1999; 274, 8316−21.
[25] Heitzer MD, DeFranco DB. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol Endocrinol, 2006; 20, 56−64. doi:  10.1210/me.2005-0065
[26] Kasai M, Guerrero-Santoro J, Friedman R, et al. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res, 2003; 63, 4927−35.
[27] Rahman MM, Miyamoto H, Lardy H, et al. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. P Natl Acad Sci Usa, 2003; 100, 5124−9. doi:  10.1073/pnas.0530097100
[28] Wu X, Chen F, Sahin A, et al. Distinct function of androgen receptor coactivator ARA70alpha and ARA70beta in mammary gland development, and in breast cancer. Breast Cancer Res Tr, 2011; 128, 391−400. doi:  10.1007/s10549-010-1131-5
[29] Wang XL, Kong F, Shen T, et al. Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells. Acta Pharmacol Sin, 2011; 32, 338−44. doi:  10.1038/aps.2010.219
[30] Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev, 2002; 23, 175−200. doi:  10.1210/edrv.23.2.0460
[31] Hodgson MC, Astapova I, Hollenberg AN, et al. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res, 2007; 67, 8388−95. doi:  10.1158/0008-5472.CAN-07-0617
[32] Guo DM, Wang YH, Qian YZ, et al. Joint acute and endocrine disruptive toxicities of malathion,cypermethrin and prochloraz to embryo-larval zebrafish, Danio rerio. Chemosphere, 2017; 166, 63−71. doi:  10.1016/j.chemosphere.2016.09.075
[33] Xu LC, Zhan NY, Liu R, et al. Joint action of phoxim and fenvalerate on reproduction in male rats. Asian J Androl, 2004; 6, 337−41.